pepmg_

Study summary · research use only

LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis

Study · Cells · 2022 · DOI 10.3390/cells11152463 · PMID 35954305

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This review discusses the amphipathic peptide LL-37, a proteolytic fragment of cathelicidin, and its role in neutrophil extracellular trap (NET) formation (NETosis). The abstract describes LL-37 as functioning as a defensin by inserting into bacterial pathogen membranes, as an alarmin stimulating chemotaxis of innate immune cells, and as a modulator of cytokine structure and activity. It focuses on LL-37's direct effect on neutrophils and NET release, noting NETs have been established as mediators of immune defense against pathogens but also as contributors to chronic disease and tissue pathology. The authors propose a structural basis for LL-37 function based on its structural flexibility and ability to adapt to different microenvironments and interacting partners. Species not specified.

Abstract

Innate immunity responds to infections and inflammatory stimuli through a carefully choreographed set of interactions between cells, stimuli and their specific receptors. Of particular importance are endogenous peptides, which assume roles as defensins or alarmins, growth factors or wound repair inducers. LL-37, a proteolytic fragment of cathelicidin, fulfills the roles of a defensin by inserting into the membranes of bacterial pathogens, functions as alarmin in stimulating chemotaxis of innate immune cells, and alters the structure and efficacy of various cytokines. Here, we draw attention to the direct effect of LL-37 on neutrophils and the release of extracellular traps (NETs), as NETs have been established as mediators of immune defense against pathogens but also as important contributors to chronic disease and tissue pathogenesis. We propose a specific structural basis for LL-37 function, in part by highlighting the structural flexibility of LL-37 and its ability to adapt to distinct microenvironments and interacting counterparts.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.